CN|EN
Subject Service Platform
Contact Us
TrialCAT
We are committed to providing leading innovative businesses to the global life sciences industry. The innovative business is patient-centric, covering two major areas: subject compensation solutions and decentralized clinical trials (DCT), and is committed to providing customers with more efficient, safer and more reliable solutions as well as promoting the digital transformation of clinical trials.
Subject Compensation

· To ensure that the compensation for subjects is "timely paid", effectively protect the rights and interests of subjects, improve patients' experience, enhance patients' satisfaction and reduce drop-out rate, from 2019, TrialNet has gradually adopted new technologies to realize online compensation for subjects.


· Up to now, it has undertaken hundreds of successful cases (the products in some projects have been tested by clinical trials and marketed), mainly registration trials, with Global projects accounting for 20%.

Scope And Explanation Of Subject Compensation
  • Transportation and nutrition expenses:
    Their names consistent with names of ICF expenses
  • Medication log, questionnaire expenses:
    Combined with remote follow-up ePRO
  • Treatment costs:
    Advance payment for hospitalization expenses, out-of-hospital treatment expenses, and medication costs of bridging therapy
  • Investigational drug:
    Advance payment for investigational drug and combined drugs
  • SAE compensation:
    Advance payment to avoid disputes
Subject Follow-up And DCT
ePRO + AI: the digital service that uses Internet software and artificial intelligence technology to manage patient compliance, collect patient data and resolve patient questions
Electronic Informed Consent

· Electronic prior informed consent

· Electronic primary informed consent

· Face recognition, ID card recognition

· Signing of the informed consent, which is authoritative, accurate and legal as it can be certified online directly via public security channel

Intelligent Follow-up

· Remote immediate communication

· Continued collection of disease data

· Direct data connection to EDC

· Intelligent patient education with videos

· Reduction of patients' drop-out rate

Drug/Sample Delivery & Local Inspection

· Samples are sent for screening after the patient sign the prior informed consent, and the investigator will assess the samples for enrollment

· Map of local examination sites for patients, appointment management (cooperative examination organizations for hemogram and lung functions, etc.)

· Drug distribution map (immediate synchronization of distribution information, 99% prefecture-level city coverage rate)

Data Security And Privacy Protection
Security Architecture
A well-established information security architecture that can ensure safe, reliable and stable operation of the platform
Multiple Certifications
Pursuit of the highest compliance certification
Verification for compliance with international standards

· Title 21 CFR Part 11 (International Basic Standard)

· CDISC (Data Interchange Standards)

· GAMP5 (System Verification Standards)

Passing ISO management certifications

· The Ministry of Public Security of the PRC: Information System Security Level Protection (Level 3)

· China Academy of Information and Communications Technology (CAICT), Ministry of Industry and Information Technology: Credible Cloud Enterprise-level SaaS Service Assessment and Certification

· Internationally certified: SOC2 type1 identification

· First Chinese enterprise among WHO-UMC certified suppliers

WHO Drug coding tool certified by WHO

· The first CDISC system member and registered supplier in China

· National High-tech Enterprise

  • ISO9001-2015
  • ISO20000-1
  • ISO27001
  • ISO27017-2015
  • ISO27018-2019
  • ISO27701-2019
  • Equal Protection 3.0

CDISC: The Clinical Data Interchange Standards Consortium

GAMP: Good Automated Manufacturing Practices

Contact Us
Please complete the form below to submit your request or questions.